Aclid Closes $3.3M Seed Funding Round

Funding Rounds

▤ Summary

Aclid, a NYC-based provider of a security and compliance automation platform for the biotechnology industry, raised $3.3M in Seed funding. The round was led by 2048 Ventures and IA Ventures. The company intends to use the funds to meet customer demand for its real-time screening and verification platform. Led by Founder and CEO Kevin Flyangolts and Harris Wang, Aclid provides a security and compliance automation platform for biotechnology. Gene synthesis providers use it to verify customers, screen DNA and RNA orders for pathogenic and toxic elements, and automate compliance checks.

$ Funding

$
Amount $3.3M Total raised
□
Date October 12, 2023 Announcement date
◎
Investors - Lead investors
▥
Company - Funded company

▥ Classifications

industries
No industries detected
applications
No applications detected

◇ AskAI Classifications

Labels
No AI classifications detected

▦ Linked Companies